These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 16866702)
1. Is age a risk factor for warfarin-related major bleeds in elderly patients with atrial fibrillation? Cheng HY J Am Geriatr Soc; 2006 Jul; 54(7):1155. PubMed ID: 16866702 [No Abstract] [Full Text] [Related]
2. Bleeding risk on warfarin among elderly patients with atrial fibrillation. Cowan A; Hylek EM J Am Coll Cardiol; 2010 Mar; 55(9):932; author reply 932-3. PubMed ID: 20185052 [No Abstract] [Full Text] [Related]
3. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Hylek EM; Evans-Molina C; Shea C; Henault LE; Regan S Circulation; 2007 May; 115(21):2689-96. PubMed ID: 17515465 [TBL] [Abstract][Full Text] [Related]
4. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation. Mant JW Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531 [No Abstract] [Full Text] [Related]
5. Oral anticoagulant therapy in patients with atrial fibrillation. Pengo V Semin Vasc Med; 2003 Aug; 3(3):333-8. PubMed ID: 15199467 [TBL] [Abstract][Full Text] [Related]
6. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy. DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704 [TBL] [Abstract][Full Text] [Related]
7. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation. Hylek EM Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532 [No Abstract] [Full Text] [Related]
8. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study. Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184 [TBL] [Abstract][Full Text] [Related]
9. Letter regarding article by Hylek et al, "Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation". Ono A; Kawamura I; Fujita T Circulation; 2007 Nov; 116(20):e538. PubMed ID: 17998467 [No Abstract] [Full Text] [Related]
10. Risk factors for bleeding during anticoagulation of atrial fibrillation in older and younger patients in clinical practice. Abdelhafiz AH; Wheeldon NM Am J Geriatr Pharmacother; 2008 Mar; 6(1):1-11. PubMed ID: 18396243 [TBL] [Abstract][Full Text] [Related]
11. Are major bleeding events from falls more likely in patients on warfarin? Garvin R; Howard E J Fam Pract; 2006 Feb; 55(2):159-60; discussion 159. PubMed ID: 16451785 [TBL] [Abstract][Full Text] [Related]
12. Major bleeding complications in a specialized anticoagulation service. Fanikos J; Grasso-Correnti N; Shah R; Kucher N; Goldhaber SZ Am J Cardiol; 2005 Aug; 96(4):595-8. PubMed ID: 16098319 [TBL] [Abstract][Full Text] [Related]
13. Bleeding rates in elderly patients on vitamin K antagonist therapy for nonvalvular atrial fibrillation. Tay KH; Lip GY; Lane DA Blood Coagul Fibrinolysis; 2009 Jul; 20(5):392-3. PubMed ID: 19542940 [No Abstract] [Full Text] [Related]
14. Assessment of risk factors for bleeding in Japanese patients with non-valvular atrial fibrillation receiving warfarin treatment: A subanalysis of the J-RHYTHM Registry. Tomita H; Okumura K; Inoue H; Atarashi H; Yamashita T; Origasa H; Int J Cardiol; 2015 Dec; 201():308-10. PubMed ID: 26301666 [No Abstract] [Full Text] [Related]
15. Cost-effectiveness of genotype-guided warfarin therapy for anticoagulation in elderly patients with atrial fibrillation. Leey JA; McCabe S; Koch JA; Miles TP Am J Geriatr Pharmacother; 2009 Aug; 7(4):197-203. PubMed ID: 19766951 [TBL] [Abstract][Full Text] [Related]
16. [The influence of CYP2C9 genetic polymorphism on the pharmacokinetics and pharmacodynamics of warfarin in patients with constant atrial fibrillation]. Sychev DA; Mikheeva IuA; Kropacheva ES; Ignat'ev IV; Bulytova IuM; Ramenskaia GV; Dobrovol'skiĭ AB; Panchenko EP; Kukes VG Klin Med (Mosk); 2007; 85(1):57-60. PubMed ID: 17419358 [TBL] [Abstract][Full Text] [Related]
17. Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls. Garwood CL; Corbett TL Ann Pharmacother; 2008 Apr; 42(4):523-32. PubMed ID: 18334606 [TBL] [Abstract][Full Text] [Related]
18. Does statin therapy decrease the risk for bleeding in patients who are receiving warfarin? Douketis JD; Melo M; Bell CM; Mamdani MM Am J Med; 2007 Apr; 120(4):369.e9-369.e14. PubMed ID: 17398234 [TBL] [Abstract][Full Text] [Related]
19. Risk of bleeding in very old atrial fibrillation patients on warfarin: relationship with ageing and CHADS2 score. Poli D; Antonucci E; Marcucci R; Fatini C; Alterini B; Mannini L; Falciani M; Abbate R; Gensini GF; Prisco D Thromb Res; 2007; 121(3):347-52. PubMed ID: 17597186 [TBL] [Abstract][Full Text] [Related]
20. Predicting the risk of bleeding in patients taking warfarin. Ebell MH Am Fam Physician; 2010 Mar; 81(6):780. PubMed ID: 20229978 [No Abstract] [Full Text] [Related] [Next] [New Search]